203 related articles for article (PubMed ID: 32931067)
1. Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis.
Hwang SM; Ahn H; Jeon S; Park J; Chang Y; Kim H
J Clin Lab Anal; 2021 Jan; 35(1):e23576. PubMed ID: 32931067
[TBL] [Abstract][Full Text] [Related]
2. Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia.
Jurado R; Huguet M; Xicoy B; Cabezon M; Jimenez-Ponce A; Quintela D; De La Fuente C; Raya M; Vinets E; Junca J; Julià-Torras J; Zamora L; Oriol A; Navarro JT; Calvo X; Sorigue M
Cytometry B Clin Cytom; 2023 Jul; 104(4):319-330. PubMed ID: 36448679
[TBL] [Abstract][Full Text] [Related]
3. High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening.
Vazquez R; Roussel M; Badaoui B; Freynet N; Tarfi S; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
Cytometry B Clin Cytom; 2018 Sep; 94(5):658-661. PubMed ID: 29108126
[TBL] [Abstract][Full Text] [Related]
4. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.
Hudson CA; Burack WR; Leary PC; Bennett JM
Am J Clin Pathol; 2018 Aug; 150(4):293-302. PubMed ID: 29982327
[TBL] [Abstract][Full Text] [Related]
6. Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia.
Picot T; Aanei CM; Flandrin Gresta P; Noyel P; Tondeur S; Tavernier Tardy E; Guyotat D; Campos Catafal L
Front Oncol; 2018; 8():109. PubMed ID: 29707521
[TBL] [Abstract][Full Text] [Related]
7. Real world implementation of flow cytometric monocyte subset partitioning for distinguishing chronic myelomonocytic leukaemia from other causes of monocytosis.
Barge L; Gooch M; Hendle M; Simleit E
Pathology; 2023 Oct; 55(6):827-834. PubMed ID: 37541805
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Xu Y; McKenna RW; Karandikar NJ; Pildain AJ; Kroft SH
Am J Clin Pathol; 2005 Nov; 124(5):799-806. PubMed ID: 16203279
[TBL] [Abstract][Full Text] [Related]
9. Incorporating flow cytometry and next-generation sequencing in the diagnosis of CMML. Are we ready for prime?
Solary E; Wagner-Ballon O; Selimoglu-Buet D
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101134. PubMed ID: 32460985
[TBL] [Abstract][Full Text] [Related]
10. A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the "Mono-dysplasia-score" combined with flow cytometric quantification of monocyte subsets.
Zhu J; Sourdeau E; Aubert H; Clauser S; Maillon A; Capron C; Jondeau K; Ronez E; Schillinger F; Garnache-Ottou F; Cornet E; Bardet V
Int J Lab Hematol; 2019 Dec; 41(6):782-790. PubMed ID: 31647610
[TBL] [Abstract][Full Text] [Related]
11. Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
Calvo X; Garcia-Gisbert N; Parraga I; Gibert J; Florensa L; Andrade-Campos M; Merchan B; Garcia-Avila S; Montesdeoca S; Fernández-Rodríguez C; Salido M; Puiggros A; Espinet B; Colomo L; Roman-Bravo D; Bellosillo B; Ferrer A; Arenillas L
Blood Adv; 2020 Oct; 4(20):5285-5296. PubMed ID: 33108455
[TBL] [Abstract][Full Text] [Related]
12. ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.
Wagner-Ballon O; Bettelheim P; Lauf J; Bellos F; Della Porta M; Travaglino E; Subira D; Lopez IN; Tarfi S; Westers TM; Johansson U; Psarra K; Karathanos S; Matarraz S; Colado E; Gupta M; Ireland R; Kern W; Van De Loosdrecht AA;
Cytometry B Clin Cytom; 2023 Jan; 104(1):66-76. PubMed ID: 34967500
[TBL] [Abstract][Full Text] [Related]
13. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.
Selimoglu-Buet D; Wagner-Ballon O; Saada V; Bardet V; Itzykson R; Bencheikh L; Morabito M; Met E; Debord C; Benayoun E; Nloga AM; Fenaux P; Braun T; Willekens C; Quesnel B; Adès L; Fontenay M; Rameau P; Droin N; Koscielny S; Solary E;
Blood; 2015 Jun; 125(23):3618-26. PubMed ID: 25852055
[TBL] [Abstract][Full Text] [Related]
14. Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis.
Tarfi S; Harrivel V; Dumezy F; Guy J; Roussel M; Mimoun A; Fenaux P; Chapuis N; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
Blood Cancer J; 2018 Nov; 8(11):114. PubMed ID: 30429467
[TBL] [Abstract][Full Text] [Related]
15. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
16. The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia.
Moon Y; Kim MH; Kim HR; Ahn JY; Huh J; Huh JY; Han JH; Park JS; Cho SR
Ann Lab Med; 2018 Sep; 38(5):481-483. PubMed ID: 29797820
[TBL] [Abstract][Full Text] [Related]
17. The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis.
Cargo C; Cullen M; Taylor J; Short M; Glover P; Van Hoppe S; Smith A; Evans P; Crouch S
Blood; 2019 Mar; 133(12):1325-1334. PubMed ID: 30606702
[TBL] [Abstract][Full Text] [Related]
18. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
Geyer JT; Tam W; Liu YC; Chen Z; Wang SA; Bueso-Ramos C; Oak J; Arber DA; Hsi E; Rogers HJ; Levinson K; Bagg A; Hassane DC; Hasserjian RP; Orazi A
Mod Pathol; 2017 Sep; 30(9):1213-1222. PubMed ID: 28548124
[TBL] [Abstract][Full Text] [Related]
19. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
Singh ZN; Post GR; Kiwan E; Maddox AM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
